Secondary Logo

Journal Logo

Most Popular Articles

Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy

May, Margaret T.; Gompels, Mark; Delpech, Valerie; More

AIDS. 28(8):1193-1202, May 15, 2014.

Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trials

Gupta, Samir K.; Post, Frank A.; Arribas, José R.; More

AIDS. 33(9):1455-1465, July 15, 2019.

Three-year durable efficacy of dolutegravir plus lamivudine in antiretroviral therapy – naive adults with HIV-1 infection

Cahn, Pedro; Sierra Madero, Juan; Arribas, José R.; More

AIDS. 36(1):39-48, January 1, 2022.

Characteristics and outcomes of adolescents living with perinatally acquired HIV within Southern Africa

Tsondai, Priscilla R.; Braithwaite, Kate; Fatti, Geoffrey; More

AIDS. 34(15):2275-2284, December 1, 2020.

Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country

Stephan, Christoph; Wolf, Timo; Goetsch, Udo; More

AIDS. 22(18):2471-2479, November 30, 2008.

Explaining continued high HIV prevalence in South Africa: socioeconomic factors, HIV incidence and sexual behaviour change among a rural cohort, 2001–2004

Hargreaves, James R; Bonell, Christopher P; Morison, Linda A; More

AIDS. 21:S39-S48, November 2007.

Long-acting cabotegravir and rilpivirine for HIV-1 suppression: switch to 2-monthly dosing after 5 years of daily oral therapy

Mills, Anthony; Richmond, Gary J.; Newman, Cheryl; More

AIDS. 36(2):195-203, February 1, 2022.

Dolutegravir/lamivudine as a first-line regimen in a test-and-treat setting for newly diagnosed people living with HIV

Rolle, Charlotte-Paige; Berhe, Mezgebe; Singh, Tulika; More

AIDS. 35(12):1957-1965, October 1, 2021.

Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in adults living with HIV

Mohapi, Lerato; Pinedo, Yvett; Osiyemi, Olayemi; More

AIDS. 36(3):373-382, March 1, 2022.

HIV-1 viral blips are associated with repeated and increasingly high levels of cell-associated HIV-1 RNA transcriptional activity

Suzuki, Kazuo; Levert, Angelique; Yeung, Julie; More

AIDS. 35(13):2095-2103, November 1, 2021.

Curable sexually transmitted infections among women with HIV in sub-Saharan Africa

Jarolimova, Jana; Platt, Laura R.; Curtis, Megan R.; More

AIDS. 36(5):697-709, April 1, 2022.

Week 96 extension results of a Phase 3 study evaluating long-acting cabotegravir with rilpivirine for HIV-1 treatment

Swindells, Susan; Lutz, Thomas; Van Zyl, Lelanie; More

AIDS. 36(2):185-194, February 1, 2022.

Exploring predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysis

Cutrell, Amy G.; Schapiro, Jonathan M.; Perno, Carlo F.; More

AIDS. 35(9):1333-1342, July 15, 2021.

Low-level viremia and virologic failure in persons with HIV infection treated with antiretroviral therapy

Fleming, Julia; Mathews, W. Christopher; Rutstein, Richard M.; More

AIDS. 33(13):2005-2012, November 1, 2019.

Internalized stigma among people living with HIV: assessing the Internalized AIDS-Related Stigma Scale in four countries

Geibel, Scott; Gottert, Ann; Friedland, Barbara A.; More

AIDS. 34:S33-S41, September 1, 2020.

Impact of nucleic acid testing relative to antigen/antibody combination immunoassay on the detection of acute HIV infection

De Souza, Mark S.; Phanuphak, Nittaya; Pinyakorn, Suteeraporn; More

AIDS. 29(7):793-800, April 24, 2015.

The People Living with HIV Stigma Index 2.0: generating critical evidence for change worldwide

Friedland, Barbara A.; Gottert, Ann; Hows, Julian; More

AIDS. 34:S5-S18, September 1, 2020.

Impact of coronavirus disease 2019 epidemics on prevention and care for HIV and other sexually transmitted infections

de Lazzari, Elisa; Martínez-Mimbrero, Alejandra; Chivite, Iván; More

AIDS. 36(6):829-838, May 1, 2022.

Do people living with HIV experience greater age advancement than their HIV-negative counterparts?

De Francesco, Davide; Wit, Ferdinand W.; Bürkle, Alexander; More

AIDS. 33(2):259-268, February 1, 2019.

Simplifying switch to second-line antiretroviral therapy in sub Saharan Africa: predicted effect of using a single viral load to define efavirenz-based first-line failure

Shroufi, Amir; Van Cutsem, Gilles; Cambiano, Valentina; More

AIDS. 33(10):1635-1644, August 1, 2019.

Coronavirus disease 2019 hospitalization outcomes in persons with and without HIV in Spain

Olalla-Sierra, Julián; Martín-Escalante, María Dolores; García-Alegría, Javier; More

AIDS. 36(5):683-690, April 1, 2022.

Interleukin 21 (IL-21)/microRNA-29 (miR-29) axis is associated with natural resistance to HIV-1 infection

Ortega, Paula A.S.; Saulle, Irma; Mercurio, Vincenzo; More

AIDS. 32(17):2453-2461, November 13, 2018.

C-reactive protein as a screening test for HIV-associated pulmonary tuberculosis prior to antiretroviral therapy in South Africa

Shapiro, Adrienne E.; Hong, Ting; Govere, Sabina; More

AIDS. 32(13):1811-1820, August 24, 2018.

Weight gain stopping/switch rules for antiretroviral clinical trials

Venter, W.D. Francois; Sokhela, Simiso; Calmy, Alexandra; More

AIDS. 35(Supplement 2):S183-S188, December 15, 2021.

Monotypic low-level HIV viremias during antiretroviral therapy are associated with disproportionate production of X4 virions and systemic immune activation

Bull, Marta E.; Mitchell, Caroline; Soria, Jaime; More

AIDS. 32(11):1389-1401, July 17, 2018.

Genetic complexity in the replication-competent latent HIV reservoir increases with untreated infection duration in infected youth

Brumme, Zabrina L.; Sudderuddin, Hanwei; Ziemniak, Carrie; More

AIDS. 33(2):211-218, February 1, 2019.

Age-disparate partnerships and incident HIV infection in adolescent girls and young women in rural South Africa

Stoner, Marie C.D.; Nguyen, Nadia; Kilburn, Kelly; More

AIDS. 33(1):83-91, January 2, 2019.

Show: